Core E: Outreach, Recruitment & Education
核心 E:外展、招聘
基本信息
- 批准号:9053426
- 负责人:
- 金额:$ 11.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmyloidAutopsyAwarenessBasic ScienceBiological MarkersBrainCaliforniaCellsChinese AmericanClinicalClinical DataClinical ResearchClinical SciencesClinical TrialsCollaborationsCommunicationCommunitiesCommunity HealthCommunity HealthcareCountyDataData CollectionDementiaDiagnosisDown SyndromeEducationEducation and OutreachEducational MaterialsEffectivenessEnrollmentEventFacultyFamily CaregiverFosteringFutureGoalsGrantHealth ProfessionalIndividualLatinoLinkMinorityMinority GroupsMinority RecruitmentMissionMonitorNewsletterOrangesParticipantPhysiciansPilot ProjectsPrevention trialRecruitment ActivityRegistriesResearchResearch PersonnelResourcesStagingStrategic PlanningStudentsSystemTrainingTraining and EducationUniversitiesWorkabstractingcohortcommunity organizationscommunity partnershipdemographicsdigitaldisease diagnosisdisease registryimprovedinduced pluripotent stem cellinnovationmeetingsneuropathologyoutreachpre-clinicalpreventprogramsscience teacherskillssuccesssymposiumtraffickingweb site
项目摘要
Core E: Outreach, Recruitment & Education Core
Project Summary/Abstract
The Outreach, Recruitment and Education (ORE) Core has two primary goals that drive the aims of the
core and its strategy for implementing successful programs. The primary goal is to recruit and retain
research participants that meet the requirements of the ADRC cohorts, the projects and pilots of the
ADRC, and clinical studies and trials. The ORE Core will support recruitment and retention in all ADRC
cohorts (longitudinal, Down syndrome, and 90+ Autopsy Study) through innovative and customized
public events, physician outreach, newsletters, digital communications, and retention/appreciation
events. In addition, the ORE Core will expand recruitment efforts to support the newly established iPS
Cell Core and the proposed AmBER registry Amyloid Biomarker Enrichment Registry (see Clinical
Core.) Biweekly meetings are held between the ORE and Clinical Cores to set recruitment goals and
monitor progress. The ORE Core will build on the successes of the past grant cycle by honing data
collection and tracking systems to improve recruitment efforts, such as targeting physicians for
additional referrals to the ADRC, and maximizing traffic on the ADRC website to convert visitors to
participants. Minority recruitment will continue to be a focus of the ORE Core, and we will engage our
community partners, local referring physicians, and our current minority participants to help us double
current Chinese-American enrollment into the longitudinal cohort, to a goal of 30%. In addition, the
Down Syndrome cohort will increase Latino enrollment, to a goal of 21%, reflecting our community
demographics. Our secondary goal is the education and training of scientific investigators and
clinicians and the programmatic education of Orange County's lay and professional community about
AD, the mission of the UCI ADRC, and the importance and impact of research. We will develop and
coordinate educational programs for UCI students, staff, and faculty to enhance collaboration and
education. We will continue our annual Southern California Alzheimer s Disease Research
Conference, now in our 25th year, participate in the annual ADC symposium with the other local ADCs,
and develop a new speakers bureau. Finally, the ORE Core recognizes the importance of
centeredness and will continue to develop cross-core collaborations that are cohesive to the overall
objectives of the UCI ADRC and advance the specific aims of each core.
核心 E:外展、招聘和教育核心
项目概要/摘要
外展、招聘和教育 (ORE) 核心有两个主要目标来推动该目标的实现
核心及其实施成功计划的战略。主要目标是招募和留住
符合 ADRC 队列、项目和试点要求的研究参与者
ADRC 以及临床研究和试验。 ORE 核心将支持所有 ADRC 的招聘和保留
通过创新和定制的队列(纵向、唐氏综合症和 90 岁以上尸检研究)
公共活动、医生外展、时事通讯、数字通信和保留/欣赏
事件。此外,ORE Core将扩大招聘力度,以支持新成立的iPS
Cell Core 和拟议的 AmBER 注册表淀粉样蛋白生物标志物富集注册表(参见临床
ORE 和临床核心之间每两周举行一次会议,以设定招募目标和
监控进度。 ORE 核心将通过磨练数据以过去资助周期的成功为基础
收集和跟踪系统,以改善招聘工作,例如针对医生
向 ADRC 进行额外推荐,并最大限度地提高 ADRC 网站上的流量以将访问者转化为
参与者。少数族裔招募将继续成为 ORE Core 的重点,我们将让我们的
社区合作伙伴、当地转诊医生和我们当前的少数族裔参与者帮助我们加倍
目前,美籍华人进入纵向队列的目标是 30%。此外,
唐氏综合症队列将增加拉丁裔入学率,目标是 21%,反映了我们的社区
人口统计。我们的次要目标是教育和培训科学研究人员和
临床医生以及奥兰治县非专业人员和专业社区的规划教育
AD、UCI ADRC 的使命以及研究的重要性和影响。我们将开发和
协调 UCI 学生、教职员工和教师的教育计划,以加强协作和
教育。我们将继续每年一度的南加州阿尔茨海默病研究
会议,现在是我们的第 25 个年头,与其他当地 ADC 一起参加年度 ADC 研讨会,
并成立一个新的发言人局。最后,ORE 核心认识到的重要性
中心性,并将继续发展与整体具有凝聚力的跨核心合作
UCI ADRC 的目标并推进每个核心的具体目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aimee Pierce其他文献
Aimee Pierce的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aimee Pierce', 18)}}的其他基金
相似国自然基金
靶向干预CD33/Aβ相互作用改善小胶质细胞功能延缓AD病理进程
- 批准号:81901072
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
Pcdh-γC5介导的神经突触异常参与AD疾病发生的分子机制研究
- 批准号:81870845
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
阿尔茨海默病疾病进程中Aβ种子的作用变化及机制研究
- 批准号:81701059
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
基于自发性糖尿病老年食蟹猴阿尔茨海默病模型的建立和评估
- 批准号:31472056
- 批准年份:2014
- 资助金额:88.0 万元
- 项目类别:面上项目
EndophilinB1对APP及A-beta的调控作用在阿尔茨海默病中的机制性研究
- 批准号:81171017
- 批准年份:2011
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 11.82万 - 项目类别:
Project 2: Biomarker Analysis, Non-Genetic Risk Factors, and Their Genetic Interactions
项目 2:生物标志物分析、非遗传风险因素及其遗传相互作用
- 批准号:
10555697 - 财政年份:2023
- 资助金额:
$ 11.82万 - 项目类别: